Bacteriological Profile of Chronic Suppurative Otitis Media and Antibiotic Susceptibility in a Tertiary Care Centre of Central Nepal
DOI:
https://doi.org/10.3126/jobh.v1i2.78914Keywords:
chronic suppurative otitis media, antibiotics, PseudomonasAbstract
Background
Chronic suppurative otitis media is one of the most common cause of hearing impairment especially in developing countries due to illiteracy, poor hygiene, respiratory infections and poverty. If left unchecked, it can cause serious local and systemic complications. The aim of the study was to determine the causative organisms and their antibiotic susceptiility pattern.
Methods
This study included total 90 patients who were clinically diagnosed as chronic suppurative otitis media having active ear discharge presenting to outpatient Department of ENT, Bharatpur hospital from May 2024 to Feb 2025.Pus swab was obtained under aseptic precautions and samples were processed in microbiological lab using standard operating protocol. For isolated bacterial strains, antibiotic susceptibility test was performed by using Kirby Bauer disc diffusion method and the results were analyzed using simple statistical techniques.
Results
The most commonly affected age group was >40 years and majority of them had unilateral disease. Females were more affected than males. The most common isolated organisms were Pseudomonas aeruginosa (47.8%) and Staphylococcus aureus (8.9%) followed by Klebsiella Pneumoniae (7.8%), E. coli (5.6%), Proteusmirabilis (5.6%), Acinetobacter (3.3%), Coagulase negative Staph aureus (2.2%) and proteus vulgaris (1.1%). Majority of the common isolated strains were sensitive to Amikacin and Levofloxacin. Ciprofloxain was found to be one of the least sensitive drugs and majority of strains were found to be resistant to Amoxyclav and third generation cephalosporins.
Conclusions
Pseudomonas aeruginosa was the most common predominant isolated organism followed by Staphylococcus aureus. It is essential to know the etiological agents of CSOM and their antimicrobial susceptibility for effective treatment and preventing both the complications and development of antibiotic resistance.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.